AARON ZARNOSKY: Open Payments
NPI 1811915721 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,465 in 122 payments from 27 companies in 2025. Trend: 2023 $1,071 · 2024 $3,820 · 2025 $15,465
Speaker / faculty: $10,476Food & beverage: $2,617Travel & lodging: $1,450Honoraria: $923
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 25 | $12,471 |
| PharmaEssentia USA Corporation | 1 | $923 |
| Novartis Pharmaceuticals Corporation | 25 | $328 |
| Merck Sharp & Dohme LLC | 8 | $209 |
| GlaxoSmithKline, LLC. | 13 | $187 |
| Syndax Pharmaceuticals, Inc. | 2 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $143 |
| Agios Pharmaceuticals, Inc. | 4 | $113 |
| Janssen Biotech, Inc. | 5 | $98 |
| Incyte Corporation | 4 | $90 |
Products named: WAYRILZ, BESREMI, KEYTRUDA, OJJAARA, KISQALI, REVUFORJ, Fabhalta, PYRUKYND.
Industry payments across MI — which companies pay providers there.
